Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02394093Phase 1Completed
Phase 1, randomised, open-label trial of aspirin in pain and fever (3 arms), sponsored by Bayer. Primary endpoints: Plasma concentration of Acetylsalicylic Acid (ASA) characterized by AUC0-t, Plasma concentration of Acetylsalicylic Acid (ASA) characterized by AUC0-infinity and 18 more. Started Feb 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02394093.